Nina Bhardwaj
Member of Scientific Advisory BoardDr. Nina Bhardwaj, M.D., Ph.D., is Internal Advisory Board Member of Cell BioEngines, Inc. from October 2025. Dr. Bhardwaj is Associate Director of Scientific Advisory Council of Cancer Research Institute, Inc. Dr. Bhardwaj is Scientific Advisor of Apricity Health, LLC. Dr. Bhardwaj serves as Member of Scientific Advisory Board at CARISMA Therapeutics Inc. since June 2020. She served as Director at American Association For Cancer Research since 2021 until 2024. She serves as Member of Scientific Advisor Board at BioNTech US Inc. (formerly known as Neon Therapeutics, Inc.). and ROME Therapeutics, Inc. Dr. Bhardwaj serves as Professor of Medicine at the New York University of Medicine and a Director of the Cancer Vaccine Program. Dr. Bhardwaj served as a Member of the Scientific Advisory Board at Cerus Corporation since May 2004. Dr. Bhardwaj has been a Member of Scientific Advisory Board at CureVac AG (CureVac N.V.) since March 2016. Dr. Bhardwaj is member of the American Society of Clinical Investigation and the American Association of Physicians; and senior editor of the AACR Cancer Immunology Research journal. Dr. Bhardwaj has extensive immunology experience: she is currently the Director of Immunotherapy, Medical Director of the Vaccine and Cell Therapy Laboratory and Co-Director of the Cancer Immunology Program at The Tisch Cancer Institute and holds the Ward Coleman Chair in Cancer Research. She has made influential contributions to human dendritic cell biology, specifically regarding isolation, biology, antigen presenting function and use as vaccine adjuvants in humans. Dr. Bhardwaj earned her Ph.D. from NYU’s Medical School, where she went on to work as a professor of medicine, pathology and dermatology as well as was the director of the tumor vaccine program.
Positions
- Company NameCarisma Therapeutics, Inc.Stock CodeCARMPositionMember of Scientific Advisory Board
